| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |